Search details
1.
The long noncoding RNA glycoLINC assembles a lower glycolytic metabolon to promote glycolysis.
Mol Cell
; 82(3): 542-554.e6, 2022 02 03.
Article
in English
| MEDLINE | ID: mdl-35081364
2.
A genomic and epigenomic atlas of prostate cancer in Asian populations.
Nature
; 580(7801): 93-99, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32238934
3.
4-Octyl itaconate alleviates experimental autoimmune prostatitis by inhibiting the NLRP3 inflammasome-induced pyroptosis through activating Nrf2/HO-1 pathway.
Prostate
; 84(4): 329-341, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38073004
4.
Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway.
Prostate
; 84(7): 666-681, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38444115
5.
Dual deficiency of melatonin and dihydrotestosterone promotes stromal cell damage and mediates prostatitis via the cGAS-STING pathway in sleep-deprived mice.
Cell Commun Signal
; 22(1): 183, 2024 03 15.
Article
in English
| MEDLINE | ID: mdl-38491517
6.
PEGylated Manganese-Zinc Ferrite Nanocrystals Combined with Intratumoral Implantation of Micromagnets Enabled Synergetic Prostate Cancer Therapy via Ferroptotic and Immunogenic Cell Death.
Small
; 19(22): e2207077, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36861297
7.
Fabrication and application of a wireless high-definition endoscopic system in urological surgeries.
BJU Int
; 131(2): 183-189, 2023 02.
Article
in English
| MEDLINE | ID: mdl-35199469
8.
Nomogram for predicting risk factors of fever in patients with negative preoperative urine culture after retrograde intrarenal surgery.
World J Urol
; 41(3): 783-789, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36773093
9.
Overexpression of DDX49 in prostate cancer is associated with poor prognosis.
BMC Urol
; 23(1): 66, 2023 Apr 27.
Article
in English
| MEDLINE | ID: mdl-37106339
10.
Feasibility and safety of bipolar-plasmakinetic transurethral enucleation and resection of the prostate in day surgery mode. / åæç离åç»å°¿éååè ºååæ¥é´ææ¯ä¸´åºå®è·µ.
Zhejiang Da Xue Xue Bao Yi Xue Ban
; 52(2): 148-155, 2023 Apr 25.
Article
in English, Zh
| MEDLINE | ID: mdl-37283098
11.
Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 23(10): 1249-1260, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36075260
12.
Establishment of a five-enzalutamide-resistance-related-gene-based classifier for recurrence-free survival predicting of prostate cancer.
J Cell Mol Med
; 26(21): 5379-5390, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36168930
13.
CXCR3 antagonist AMG487 ameliorates experimental autoimmune prostatitis by diminishing Th1 cell differentiation and inhibiting macrophage M1 phenotypic activation.
Prostate
; 82(13): 1223-1236, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35700340
14.
Identification of novel susceptibility factors related to CP/CPPS-like symptoms: Evidence from a multicenter case-control study.
Prostate
; 82(7): 772-782, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35188987
15.
CD274 (PD-L1) Methylation is an Independent Predictor for Bladder Cancer Patients' Survival.
Cancer Invest
; 40(3): 228-233, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35020560
16.
Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer.
Cancer Cell Int
; 22(1): 382, 2022 Dec 05.
Article
in English
| MEDLINE | ID: mdl-36471446
17.
Effects of iron oxide nanoparticles as T2-MRI contrast agents on reproductive system in male mice.
J Nanobiotechnology
; 20(1): 98, 2022 Mar 02.
Article
in English
| MEDLINE | ID: mdl-35236363
18.
hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis.
Med Sci Monit
; 28: e938012, 2022 Oct 31.
Article
in English
| MEDLINE | ID: mdl-36310366
19.
Associated Factors for Prostate Enlargement in Chinese Adult Men Aged <40 Receiving Checkups.
Int J Clin Pract
; 2022: 4792451, 2022.
Article
in English
| MEDLINE | ID: mdl-36016826
20.
Recurrent Prostatic Stromal Tumor of Uncertain Malignant Potential Combined with Concurrent Prostatic Adenocarcinoma: An Unusual Case.
Urol Int
; 106(9): 974-978, 2022.
Article
in English
| MEDLINE | ID: mdl-34229324